Dhaka, Bangladesh (BBN)– The board of directors of Ambee Pharmaceuticals Ltd has recommended 30 percent cash dividend for the year ended on June 30, 2018.
The final approval of dividend will come during the annual general meeting (AGM) scheduled to be held on December 27, 2018, said an official disclosure on Tuesday.
The record date for AGM is on December 04.
The company has also reported earnings per share (EPS) of BDT 3.44, net asset value (NAV) per share of BDT 25.68 and NOCFPS of BDT 7.76 for the year ended on June 30, 2018 as against BDT 3.02, BDT 25.24 and BDT 7.59 respectively for the same period of the previous year.
The company, which was listed on the Dhaka bourse in 1986, also disbursed 30 percent cash dividend in 2017.
Each share of the company closed at BDT 585.30 on Monday at Dhaka Stock Exchange.
There will be no price limit today on the trading of shares of the company following its corporate disclosure.
The company’s paid-up capital is BDT 24 million and authorised capital is BDT 25 million, while total number of securities is 2.40 million, according to statistics from the DSE.
The sponsor-directors own 75.26 percent stake in the company, while the institutional investors own 3.07 percent and the general public 21.67 percent as on October 31, 2018.